NCT05883072Recruiting
Exploring the Effectiveness of AI Generative Models for Diabetic Patients
Source: ClinicalTrials.gov · Last updated 5 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 9 Mar 2023
- Start date
- 5 Jan 2023
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Pakistan Council of Scientific and Industrial Research
- Diseases
- Type 2 diabetes, Diabetic eye disease
- NCT number
- NCT05883072
What you commit to
- Study type: Observational
- Planned participants: 300
- From 5 Jan 2023 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
Who the study is looking for
- Present physically in Pakistan
- Adults (18 years or older)
- Diabetic Patient
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CDLE, PCSIR Lbas Complex Coordinator of this site? Confirm its status | Karachi | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.